Skip to content
Abierto

Award notice, total small business set-aside

Nanovaccine for Eliciting Broadly Neutralizing Antibodies against HIV-1

75N93024C00019

National Institutes of Health, National Institutes of Health Niaid. Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology).

Awarded

Neovaxsyn Inc.

$2,000,000.00 on the award notice, June 25, 2024, contract 75N93024C00019

The contract, on USAspending

Federal procurement data the awarding office reported to FPDS, matched to this solicitation by its number.

UEI
EHMTBALCKFE8
CAGE
7RK00
Vendor location
Ames, IA
Contract
75N93024C00019, definitive contract
Obligated
$2,000,000.00
Actions
2 between June 25, 2024 and June 25, 2026
Competition
Full and Open Competition After Exclusion of Sources, 2 offers received
Set-aside reported
Small Business Set Aside - Total
Described as
Nanovaccine for Eliciting Bnabs Against HIV-1
Match
award number 75N93024C00019 equals the contract number; same awarding office 75N930 (high confidence)

Publications

Every notice SAM.gov issued under this solicitation number, oldest first. Each is a separate record on SAM.

  1. July 1, 2024

    Award notice

    Awarded to NEOVAXSYN Inc. Ames for $2,000,000. SAM.gov, notice 73b10a8dcc7541e29ed05495fc04fd9a

  2. January 14, 2025

    Award notice

    Awarded to NEOVAXSYN Inc. Ames for $2,000,000. SAM.gov, notice dd394377adbf4116aaf84d47abc943ca

Points of contact